Table 3.
*Patients 5 and 8 were previously crossmatch-positive by FCM for both T cells and B cells; †Previous DSA detected by PRA.
M, male; F, female; Prev TX, previous transplantation; Prev TF, previous transfusion; AHG-CDC, antihuman globulin-enhanced complement-dependent cytotoxicity; FCM, flow-cytometry; PRA, panel-reactive antibody; DSA, donor-specific antibody.